0000000000123987

AUTHOR

Thomas Rostock

showing 22 related works from this author

Propofol sedation administered by cardiologists without assisted ventilation for long cardiac interventions: an assessment of 1000 consecutive patien…

2011

Aims Patients can expect a cure from atrial fibrillation (AF) with ablation. Procedural safety and success depend on patient comfort, compliance, and immobility. This is difficult to achieve with benzodiazepine and opiate boluses that are the mainstay of current practice. We sought to determine the safety and efficacy of propofol infusion sedation administered to patients without assisted ventilation for AF ablation. Methods and results Procedural data from 1000 consecutive patients undergoing AF ablation were analysed. Sedation with 2% propofol was used in all procedures without assisted ventilation and was administered, monitored, and controlled by electrophysiologists. Primary outcome me…

Malemedicine.drug_classMidazolamSedationCohort StudiesBolus (medicine)Physiology (medical)Atrial FibrillationmedicineHumansAdverse effectPropofolAgedbusiness.industryPericardiocentesisAtrial fibrillationSialorrheaMiddle Agedmedicine.diseaseCardiac TamponadeTreatment OutcomeBlood pressureAnesthesiaSedativeCatheter AblationMidazolamFemaleDeep SedationHypotensionmedicine.symptomRespiratory InsufficiencyCardiology and Cardiovascular MedicinebusinessPropofolAnesthetics Intravenousmedicine.drugEuropace
researchProduct

Cardiovascular Magnetic Resonance Demonstrates Reversible Atrial Dysfunction After Catheter Ablation of Persistent Atrial Fibrillation

2013

Reversible Dysfunction After Persistent AF Ablation Introduction There is a paucity of data on atrial injury following ablation of persistent atrial fibrillation (AF). This study aimed at assessing reversibility of atrial dysfunction after successful persistent AF ablation using cardiovascular magnetic resonance (CMR). Methods and Results CMR was performed during sinus rhythm (SR) in 20 consecutive patients with persistent AF at baseline (BL) within 24 hours after ablation and after 6-month follow-up (FU). Catheter ablation included atrial substrate modification using the stepwise approach following pulmonary vein isolation (PVI) in order to attempt termination of persistent AF. Active left…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentMagnetic resonance imagingCatheter ablationAtrial fibrillationAblationmedicine.diseasePulmonary veinPhysiology (medical)Internal medicineEdemaPersistent atrial fibrillationcardiovascular systemCardiologyMedicineSinus rhythmcardiovascular diseasesmedicine.symptomCardiology and Cardiovascular MedicinebusinessJournal of Cardiovascular Electrophysiology
researchProduct

Primary Persistent Atrial Fibrillation: A Distinct Arrhythmia Subentity of an Ablation Population

2015

INTRODUCTION Persistent atrial fibrillation (persAF) can occur either as a sustained arrhythmia that has progressed from initially paroxysmal AF or as primary persAF without a history of any spontaneously terminated episode. There is a paucity of data differentiating between the 2 different persAF entities. Thus, we prospectively evaluated baseline characteristics, electrophysiological features, and ablation outcome in these 2 patient cohorts. METHODS AND RESULTS A total number of 154 consecutive persAF patients (63 ± 10 years, f = 42, longstanding persAF = 60) were characterized in terms of having primary persAF (P-persAF group) or persAF that secondarily progressed from paroxysmal AF (S-p…

medicine.medical_specialtyeducation.field_of_studybusiness.industrymedicine.medical_treatmentPopulationCatheter ablationAtrial fibrillationAblationmedicine.diseasePhysiology (medical)Heart failurePredictive value of testsInternal medicineCardiologyMedicineMedical historyCardiology and Cardiovascular MedicinebusinessProspective cohort studyeducationJournal of Cardiovascular Electrophysiology
researchProduct

Reduction of ICD Shock Burden by Eliminating Back-Up Pacing Induced Ventricular Tachyarrhythmias

2014

ICD Shock Reduction by Subthreshold Pacing Introduction Implantable cardioverter defibrillators (ICD) may have the capacity to provoke or worsen ventricular tachyarrhythmias (VT). It has been reported that ICD shocks by itself can increase mortality. This study aimed to determine the role of back-up pacing-induced VT (PIT) in the overall ICD shock burden by avoiding pause-related ventricular back-up pacing. Methods and Results A population of 550 single-chamber ICD patients was studied. Of them, 17 (3%, 69 ± 16 years, 14 male) patients had documented episodes of PIT. A total of 431 VT episodes were documented including 89 (21%) due to PIT. In 3 patients, VT events were exclusively PITs. Aft…

Proarrhythmiaeducation.field_of_studymedicine.medical_specialtyVentricular Tachyarrhythmiasbusiness.industrymedicine.medical_treatmentPopulationImplantable cardioverter-defibrillatormedicine.diseaseVentricular tachycardiaSudden deathPhysiology (medical)Internal medicineShock (circulatory)medicineCardiologymedicine.symptomIcd shocksCardiology and Cardiovascular MedicineeducationbusinessJournal of Cardiovascular Electrophysiology
researchProduct

Prognostic Role of Subsequent Atrial Tachycardias Occurring During Ablation of Persistent Atrial Fibrillation

2013

Background— The role of subsequent atrial tachycardias (AT) in the context of persistent atrial fibrillation (AF) remains undetermined. This study evaluated the prognostic role of subsequent ATs for arrhythmia recurrences after catheter ablation of persistent AF. Methods and Results— A total of 110 patients with persistent AF (63±9 years; 22 women; 61 long-lasting persistent AF) underwent pulmonary vein isolation followed by electrogram-guided ablation. After AF terminated to AT, patients were separated by the randomization protocol to receive either direct cardioversion (group A) or further ablation of subsequent ATs to sinus rhythm (group B). After a mean follow-up of 20.1±13.3 months af…

MaleTachycardia Ectopic Atrialmedicine.medical_specialtyRandomizationmedicine.medical_treatmentElectric CountershockContext (language use)Catheter ablationKaplan-Meier EstimateCardioversionlaw.inventionRandomized controlled triallawPhysiology (medical)Internal medicineAtrial FibrillationmedicineHumansSinus rhythmProspective StudiesAgedbusiness.industryAtrial fibrillationMiddle AgedPrognosisAblationmedicine.diseaseSurgeryCatheter AblationCardiologyFemaleCardiology and Cardiovascular MedicinebusinessCirculation: Arrhythmia and Electrophysiology
researchProduct

Impact of Structural Heart Disease on the Acute Complication Rate in Atrial Fibrillation Ablation: Results from the German Ablation Registry

2013

Acute Complication Rate in AF Ablation Introduction Catheter ablation (CA) has emerged as a widespread therapeutic option in the treatment of atrial fibrillation (AF). Currently, no safety data with regard to the impact of the underlying structural heart diseases (SHD) are available. We sought to assess the risk for acute and long-term complications during CA of AF in relation to underlying SHD. Methods and Results We included 6,211 patients in a prospective registry undergoing CA of AF in 41 nationwide centers. All patients were divided into 4 groups according to the underlying heart disease: No SHD (69.4%), hypertensive heart disease (HHD) (12.0%), coronary artery disease (CAD) (15.1%), a…

medicine.medical_specialtyUnivariate analysisHeart diseasebusiness.industrymedicine.medical_treatmentCardiomyopathyAtrial fibrillationCatheter ablationOdds ratiomedicine.diseaseHypertensive heart diseaseCoronary artery diseasePhysiology (medical)Internal medicinemedicineCardiologyCardiology and Cardiovascular MedicinebusinessJournal of Cardiovascular Electrophysiology
researchProduct

A 35-year effective treatment of catecholaminergic polymorphic ventricular tachycardia with propafenone

2018

Key Teaching Points • Despite proven catecholaminergic polymorphic ventricular tachycardia (CPVT) with pathogen RyR2 mutation and recurrent syncope, patients could have a favorable long-term outcome over 35 years under treatment. • Propafenone could be effective for treatment of patients with CPVT. • The beneficial effect of the monotherapy with propafenone in our patient may result from the combined antiarrhythmic effect of this drug with Na+ channel blockade and beta blocker capabilities.

medicine.medical_specialtyPolymorphic premature ventricular beatsmedicine.drug_classCase ReportPropafenone030204 cardiovascular system & hematologyCatecholaminergic polymorphic ventricular tachycardiaRyanodine receptor 203 medical and health sciences0302 clinical medicinePropafenoneInternal medicineMedicineEffective treatment030212 general & internal medicineExercise-induced syncopeBeta blockerbusiness.industrymedicine.diseaseBlockadeExercise-induced syncopeCatecholaminergic polymorphic ventricular tachycardiacardiovascular systemCardiologyAntiarrhythmic effectCardiology and Cardiovascular MedicinebusinessRyanodine receptor mutationmedicine.drugHeartRhythm Case Reports
researchProduct

Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.

2015

Background— In the meantime, catheter ablation is widely used for the treatment of persistent atrial fibrillation (AF). There is a paucity of data about long-term outcomes. This study evaluates (1) 5-year single and multiple procedure success and (2) prognostic factors for arrhythmia recurrences after catheter ablation of persistent AF using the stepwise approach aiming at AF termination. Methods and Results— A total of 549 patients with persistent AF underwent de novo catheter ablation using the stepwise approach (2007–2009). A total of 493 patients were included (Holter ECGs ≥every 6 months). Mean follow-up was 59±16 months with 2.1±1.1 procedures per patient. Single and multiple procedu…

AdultMaleReoperationmedicine.medical_specialtyTime Factorsmedicine.medical_treatmentCatheter ablationKaplan-Meier EstimateDisease-Free SurvivalYoung AdultSex FactorsHeart RatePredictive Value of TestsRecurrenceRisk FactorsPhysiology (medical)Internal medicineHeart rateAtrial FibrillationmedicineTachycardia SupraventricularHumans610 Medicine & healthAgedRetrospective StudiesAged 80 and overbusiness.industryAtrial fibrillationRetrospective cohort studyMiddle Agedmedicine.diseaseSurgeryTreatment OutcomeAtrial FlutterPredictive value of testsPersistent atrial fibrillationMultivariate AnalysisCardiologyCatheter AblationElectrocardiography AmbulatoryFemaleCardiology and Cardiovascular MedicinebusinessStepwise approachAnti-Arrhythmia AgentsAtrial flutterFollow-Up StudiesCirculation. Arrhythmia and electrophysiology
researchProduct

Device Therapy for Rate Control: Pacing, Resynchronisation and AV Node Ablation

2017

Atrioventricular node ablation (AVNA) is generally reserved for patients whose atrial fibrillation (AF) is refractory all other therapeutic options, since the recipients will often become pacemaker dependent. In such patients, this approach may prove particularly useful, especially if a tachycardia-induced cardiomyopathy is suspected. Historically, an "ablate and pace" approach has involved AVNA and right ventricular pacing, with or without an atrial lead. There is also an evolving role for atrioventricular node ablation in patients with AF who require cardiac resynchronisation therapy for treatment of systolic heart failure. A mortality benefit over pharmacotherapy has been demonstrated in…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyCardiomyopathy030204 cardiovascular system & hematologyCardiac Resynchronization Therapy03 medical and health sciences0302 clinical medicinePharmacotherapyRefractoryHeart RateAtrioventricular node ablationInternal medicineAtrial FibrillationmedicineHumanscardiovascular diseases030212 general & internal medicinebusiness.industryCardiac Pacing ArtificialAtrial fibrillationmedicine.diseaseAtrial LeadHeart failureAtrioventricular NodeCatheter Ablationcardiovascular systemCardiologyObservational studyCardiology and Cardiovascular MedicinebusinessHeart, Lung and Circulation
researchProduct

Simplifying atrial fibrillation ablation: how far can we go?

2013

The procedural end point of electrical isolation of the pulmonary veins (PVs) for the treatment of atrial fibrillation (AF) has been debated extensively. After identifying the PVs as the dominant arrhythmogenic site of paroxysmal AF, 2 fundamentally different approaches to the interventional treatment of AF were introduced. Haissaguerre et al developed a technique to electrically isolate the PVs by targeting electrophysiological (EP) breakthroughs from the left atrium to the PVs guided by a circular mapping catheter. In contrast, Pappone et al implemented an anatomical approach that used circumferential ablation lines around the PVs guided by a 3-dimensional mapping system. This latter appr…

Malemedicine.medical_specialtymedicine.medical_treatmentLeft atriumCryosurgeryElectrical isolationHeart Conduction SystemPhysiology (medical)Internal medicineAtrial FibrillationmedicineHumansParoxysmal AFMonitoring PhysiologicInterventional treatmentbusiness.industryCardiac arrhythmiaAtrial fibrillationAblationmedicine.diseasemedicine.anatomical_structurePulmonary VeinsMapping systemcardiovascular systemCardiologyCatheter AblationFemaleCardiology and Cardiovascular MedicinebusinessElectrophysiologic Techniques CardiacHeart rhythm
researchProduct

Correlation between atrial fibrillation driver locations and complex fractionated atrial electrograms in patients with persistent atrial fibrillation.

2018

Introduction The aim of this study was to evaluate a spatial correlation between active atrial fibrillation (AF) drivers measured by electrocardiographic imaging and complex fractionated atrial electrograms (CFAEs) in patients with persistent AF. Methods Sixteen patients with persistent AF were included. A biatrial geometry relative to an array of 252-body-surface-electrodes was obtained from a noncontrast computed tomography scan. The reconstructed unipolar AF electrograms were signal-processed (ECVUE™, CardioInsight Technologies Inc., Cleveland, OH, USA) to identify AF drivers. Before driver ablation, a biatrial mapping using the NavX system (St. Jude Medical, St. Paul, MN, USA) was perfo…

Malemedicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematologyArticleCorrelation03 medical and health sciencesElectrocardiography0302 clinical medicineInternal medicineAtrial FibrillationmedicineHumansIn patient030212 general & internal medicineCoronary sinusAgedAtrium (architecture)business.industryBody Surface Potential MappingAtrial fibrillationSignal Processing Computer-AssistedGeneral MedicineMiddle Agedmedicine.diseaseAblationmedicine.anatomical_structureTreatment OutcomePersistent atrial fibrillationCardiologyCatheter AblationRight atriumFemaleCardiology and Cardiovascular MedicinebusinessTomography X-Ray Computedhuman activitiesPacing and clinical electrophysiology : PACE
researchProduct

Stepwise Approach to Atrial Fibrillation Mapping and Ablation in Persistent and Long-standing Persistent Atrial Fibrillation

2019

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentInternal medicinePersistent atrial fibrillationmedicineCardiologyCatheter ablationAtrial fibrillationAblationmedicine.diseasebusinessStepwise approach
researchProduct

Cardiac arrhythmias in patients with Danon disease.

2016

Aims Different cardiac arrhythmias have been suggested to be associated with Danon disease, e.g. Wolff–Parkinson–White syndrome. However, a systematic electrophysiological investigation of patients with Danon disease is lacking thus far. Methods and results Seven patients with Danon disease (4 males, 35.8 ± 10.8 years; 3 females, 51.3 ± 19.9 years) from 3 different families were studied. In all patients, the presence of Danon disease was confirmed by western blot of biopsy material or genetic testing. The patients were characterized by 12-lead electrocardiogram (ECG), Holter ECG, echocardiography, and serial implantable cardioverter defibrillator (ICD) interrogations (in ICD recipients). Al…

AdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentElectric CountershockAction Potentials030204 cardiovascular system & hematologyAsymptomaticSudden cardiac death03 medical and health sciencesQRS complex0302 clinical medicineHeart RateRisk FactorsPhysiology (medical)Internal medicineMedicineHumansDanon diseasecardiovascular diseasesPR intervalAgedbusiness.industryCardiac arrhythmiaAtrial fibrillationArrhythmias CardiacMiddle AgedImplantable cardioverter-defibrillatormedicine.diseaseGlycogen Storage Disease Type IIbDefibrillators ImplantablePrimary PreventionDeath Sudden CardiacEchocardiographycardiovascular systemCardiologyAtrioventricular NodeElectrocardiography AmbulatoryFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessElectrophysiologic Techniques Cardiac030217 neurology & neurosurgeryEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
researchProduct

Atrial Fibrillation Manifestations Risk Factors and Sex Differences in a Population-Based Cohort (From the Gutenberg Health Study)

2018

Sex differences in cardiovascular risk factors, cardiac structure and function, and disease and symptom burden in the common arrhythmia atrial fibrillation (AF) have not been investigated systematically at the population level. Cross-sectional data of 14,796 subjects (age range 35 to 74 years, 50.5% men) from the population-based Gutenberg Health Study were examined to show the distribution of cardiovascular risk factors by AF status and sex, and to determine sex-specific predictors for AF. The prevalence of AF was higher in men (4.3%) than in women (1.9%). Men had a worse cardiovascular risk factor profile, a higher prevalence of cardiovascular disease, but fewer symptoms than women. Age-a…

AdultMalemedicine.medical_specialtyCross-sectional studyHeart VentriclesPopulation030204 cardiovascular system & hematologyRisk AssessmentVentricular Function LeftCoronary artery diseaseElectrocardiography03 medical and health sciencesSex Factors0302 clinical medicineRisk FactorsGermanyInternal medicineAtrial FibrillationPrevalenceHumansMedicine030212 general & internal medicineMyocardial infarctionRisk factoreducationAgedRetrospective Studieseducation.field_of_studybusiness.industryIncidenceRetrospective cohort studyAtrial fibrillationOdds ratioMiddle Agedmedicine.disease3. Good healthSurvival RateCross-Sectional StudiesEchocardiographyPopulation SurveillanceCardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesThe American Journal of Cardiology
researchProduct

History of deep vein thrombosis is a discriminator for concomitant atrial fibrillation in pulmonary embolism.

2015

Pulmonary embolism (PE) is the consequence of deep vein thrombosis (DVT) in 70% of all cases. Although, PE and DVT are commonly related to risk factors of Virchow's triad, both entities are linked to cardiovascular risk factors, but risk factors seem differently important in both entities.We aimed to investigate clinical profile and outcome of patients with PE history stratified by concomitant DVT.Data from the observational multi-center thrombEVAL-study were analyzed.The sample (N=2,318) comprised 295 PE patients, of whom 69.2% (N=204) had DVT. Individuals without DVT were older and had higher prevalence of concomitant atrial fibrillation (AF), chronic lung diseases, coronary artery diseas…

Malemedicine.medical_specialtyDeep veinCoronary artery diseaseRisk FactorsInternal medicineAtrial FibrillationmedicineHumanscardiovascular diseasesAgedAged 80 and overVenous Thrombosisbusiness.industryAtrial fibrillationHematologyOdds ratiomedicine.diseaseThrombosisPulmonary embolismVenous thrombosismedicine.anatomical_structureHeart failureCardiologyFemalebusinessPulmonary EmbolismThrombosis research
researchProduct

Impact of biatrial defragmentation in patients with paroxysmal atrial fibrillation: Results from a randomized prospective study

2014

Single procedure success rates of pulmonary vein isolation (PVI) in patients with paroxysmal atrial fibrillation (PAF) are still unsatisfactory. In patients with persistent atrial fibrillation (AF), ablation of complex fractionated atrial electrograms (CFAEs) after PVI results in improved outcomes.We aimed to investigate if PAF-patients with intraprocedurally sustained AF after PVI might benefit from additional CFAE ablation.A total of 1134 consecutive patients underwent a first catheter ablation procedure of PAF between June 2008 and December 2012. In most patients, AF was either not inducible or terminated during PVI. In 68 patients (6%), AF sustained after successful PVI. These patients …

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentElectric CountershockCatheter ablationCardioversionPulmonary veinHeart Conduction SystemHeart RatePhysiology (medical)Internal medicineAtrial FibrillationmedicineHumansSinus rhythmProspective StudiesTachycardia ParoxysmalProspective cohort studyAtrial tachycardiabusiness.industryAtrial fibrillationMiddle Agedmedicine.diseaseAblationTreatment OutcomePulmonary VeinsAnesthesiaCatheter AblationCardiologyFemalemedicine.symptomElectrophysiologic Techniques CardiacCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesHeart Rhythm
researchProduct

Systematic ajmaline challenge in patients with long QT 3 syndrome caused by the most common mutation: a multicentre study

2016

Aims Overlap syndromes of long QT 3 syndrome (LQT3) and the Brugada syndrome (BrS) have been reported. Identification of patients with an overlapping phenotype is crucial before initiation of Class I antiarrhythmic drugs for LQT3. Aim of the present study was to elucidate the yield of ajmaline challenge in unmasking the Brugada phenotype in patients with LQT3 caused by the most common mutation, SCN5A-E1784K. Methods and results Consecutive families in tertiary referral centres diagnosed with LQT3 caused by SCN5A-E1784K were included in the study. Besides routine clinical work-up, ajmaline challenge was performed after informed consent. A total of 23 subjects (11 female, mean age 27 ± 14 yea…

0301 basic medicinemedicine.medical_specialtymedicine.diagnostic_testbusiness.industryLong QT syndromeOverlap syndrome030204 cardiovascular system & hematologymedicine.diseaseSudden cardiac death03 medical and health sciencesAjmaline030104 developmental biology0302 clinical medicineEndocrinologyPhysiology (medical)Internal medicineMutation (genetic algorithm)medicineCardiologyFamily historyCardiology and Cardiovascular MedicinebusinessElectrocardiographyBrugada syndromemedicine.drugEP Europace
researchProduct

The Incidence of Audible Steam Pops Is Increased and Unpredictable With the ThermoCool® Surround Flow Catheter During Left Atrial Catheter Ablation: …

2015

Audible Steam Pops During Left Atrial Catheter AblationIntroduction Open irrigated radiofrequency (RF) ablation catheters with a porous tip (56 holes, TC-SF) permit delivering RF energy in a temperature-controlled mode without temperature rise. This prospective observational study investigated the association of different catheter parameters on the occurrence of audible steam pops during left atrial (LA) ablation. Methods and Results A total of 226 patients underwent TC-SF catheter ablation for atrial fibrillation. RF power delivery, impedance and catheter tip temperature were continually recorded throughout the ablation. Pulmonary vein isolation was performed with a maximum of 27 W and LA …

medicine.medical_specialtygenetic structuresbusiness.industrymedicine.medical_treatmentAtrial fibrillationCatheter ablationAblationmedicine.diseasePulmonary veinSurgeryCatheterLeft atrialPhysiology (medical)Internal medicineCardiac tamponademedicineCardiologyTamponadeCardiology and Cardiovascular MedicinebusinessJournal of Cardiovascular Electrophysiology
researchProduct

Arrhythmia Termination Versus Elimination of Dormant Pulmonary Vein Conduction as a Procedural End Point of Catheter Ablation for Paroxysmal Atrial F…

2015

Background— Pulmonary vein isolation (PVI) is still associated with a substantial number of arrhythmia recurrences in paroxysmal atrial fibrillation (AF). This prospective, randomized study aimed to compare 2 different procedural strategies. Methods and Results— A total of 152 patients undergoing de novo ablation for paroxysmal AF were randomized to 2 different treatment arms. The procedure in group A consisted of PVI exclusively. In this group, all isolated PVs were challenged with adenosine to reveal and ablate dormant conduction. In group B, PVI was performed with the patient either in spontaneous or in induced AF. If AF did not terminate with PVI, ablation was continued by targeting ex…

Malemedicine.medical_specialtyAdenosine5Endpoint Determinationpulmonary veinsmedicine.medical_treatmentCatheter ablation22law.inventionPulmonary veinElectrocardiographyRandomized controlled triallawRecurrencePhysiology (medical)Internal medicineAtrial Fibrillationcatheter ablationmedicineHumansSinus rhythmProspective StudiesProspective cohort studyAgedmedicine.diagnostic_testbusiness.industryAtrial fibrillationOriginal ArticlesMiddle Agedarrhythmias cardiacmedicine.diseaseAblationfollow-up studiesTreatment OutcomeAnesthesiaCardiologyFemaleCardiology and Cardiovascular MedicinebusinessElectrocardiographyAnti-Arrhythmia AgentsCirculation. Arrhythmia and electrophysiology
researchProduct

Annoyance to different noise sources is associated with atrial fibrillation in the Gutenberg Health Study

2018

Abstract Background Annoyance is a common reaction in populations exposed to environmental noise and is associated with cardiovascular diseases. We investigated for the first time the existence of an association between noise annoyance and atrial fibrillation (AF). Methods and results Cross-sectional data from 14,639 participants of the Gutenberg Health Study were collected between 2007 and 2012. Annoyance from road traffic, aircraft, railways, industrial/construction and neighbourhood noise during daytime and sleep were collected from all participants through questionnaires using a 5-point scale. AF was assessed via self-reported medical history and/or documentation of AF on the study elec…

Malemedicine.medical_specialtyTime FactorsAircraft noiseCross-sectional studyIndustrial noiseAnnoyance030204 cardiovascular system & hematologyAudiology03 medical and health sciences0302 clinical medicineRisk FactorsGermanySurveys and QuestionnairesAtrial FibrillationmedicineHumansSleep Hygiene030212 general & internal medicineCorrelation of DataEnvironmental noiseAgedbusiness.industryEnvironmental ExposureOdds ratioMiddle AgedIrritable MoodConfidence intervalNoiseCross-Sectional StudiesFemaleNoiseCardiology and Cardiovascular Medicinebusinesshuman activitiesInternational Journal of Cardiology
researchProduct

Prospective risk stratification of sudden cardiac death in Marfan's syndrome.

2013

Marfan syndrome (MFS) is a variable, autosomal-dominant disorder of the connective tissue. In MFS serious ventricular arrhythmias and sudden cardiac death (SCD) can occur. The aim of this prospective study was to reveal underlying risk factors and to prospectively investigate the association between MFS and SCD in a long-term follow-up.77 patients with MFS were included. At baseline serum N-terminal pro-brain natriuretic peptide (NT-proBNP), transthoracic echocardiogram, 12-lead resting ECG, signal-averaged ECG (SAECG) and a 24-h Holter ECG with time- and frequency domain analyses were performed. The primary composite endpoint was defined as SCD, ventricular tachycardia (VT), ventricular fi…

AdultMalecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyCardiomyopathyVentricular tachycardiaRisk AssessmentSudden cardiac deathMarfan SyndromeYoung AdultInternal medicineClinical endpointMedicineHumanscardiovascular diseasesProspective StudiesUltrasonographybusiness.industryHazard ratioMiddle Agedmedicine.diseaseSignal-averaged electrocardiogramDeath Sudden CardiacVentricular fibrillationCardiologyFemaleTransthoracic echocardiogramCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesInternational journal of cardiology
researchProduct

Automatic Holter electrocardiogram analysis in ischaemic stroke patients to detect paroxysmal atrial fibrillation : ready to replace physicians?

2020

Background and purpose The detection of paroxysmal atrial fibrillation (pAF) in patients presenting with ischaemic stroke shifts secondary stroke prevention to oral anticoagulation. In order to deal with the time- and resource-consuming manual analysis of prolonged electrocardiogram (ECG)-monitoring data, we investigated the effectiveness of pAF detection with an automated algorithm (AA) in comparison to a manual analysis with software support within the IDEAS study [study analysis (SA)]. Methods We used the dataset of the prospective IDEAS cohort of patients with acute ischaemic stroke/transient ischaemic attack presenting in sinus rhythm undergoing prolonged 72-h Holter ECG with central a…

medicine.medical_specialtyParoxysmal atrial fibrillation610 MedizinBrain Ischemia03 medical and health sciencesElectrocardiography0302 clinical medicineInternal medicinePhysicians610 Medical sciencesIschaemic strokeAtrial FibrillationmedicineHumansSinus rhythm030212 general & internal medicineProspective StudiesStrokeIschemic Strokebusiness.industryCerebral infarctionAtrial fibrillationHolter electrocardiogrammedicine.diseaseNeurologyCohortCardiologyElectrocardiography AmbulatoryNeurology (clinical)business030217 neurology & neurosurgery
researchProduct